Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FVYN4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,428
Award facts
- Contract value 100% obligated
- $23,427.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,427.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections on January 27, 2026, with an ultimate completion date of January 28, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania facility. The order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Dupixent is a biologic medication used to treat atopic dermatitis, asthma, and other allergic conditions, reflecting the comprehensive pharmaceutical supply capabilities AmerisourceBergen maintains across the federal health system. As a major pharmaceutical distributor, AmerisourceBergen and its parent organization consistently supply brand-name and generic medications, vaccines, and specialized healthcare commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions through their extensive contract portfolio with the Defense Logistics Agency and other federal health agencies.
Quick answers
Who was awarded contract SPE2DR26FVYN4?
SPE2DR26FVYN4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FVYN4 worth?
The government has obligated $23,428 on SPE2DR26FVYN4.
Is contract SPE2DR26FVYN4 an order under another contract?
Yes. SPE2DR26FVYN4 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.
Was contract SPE2DR26FVYN4 competed?
The extent of competition for SPE2DR26FVYN4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award